All
How to Prioritize Potential NDI Notifications
FDA’s revised new dietary ingredient (NDI) draft guidance raises the specter of thousands of new NDI notifications. But which are most pressing?
How Should FDA Define the Word Natural? Should It Be Different from Organic? Or Non-GMO?
As FDA looks to define the term "natural" on food labeling, industry leaders are split on what exactly the term should mean.
Protecting the Fellows: Dietary Supplements for Prostate Health
Botanical ingredients for prostatic and urological health
New GMP Standard from NSF’s GRMA Nearly Complete
The Global Retailer and Manufacturer Alliance (GRMA) expects to release its new, ANSI-approved GMP standard for the dietary supplement industry in early 2017.
Pet Health Supplements: Paw-Portunity Knocks
Supplement manufacturers are expanding into the pet market in increasing numbers while barriers to entry are low.
Energy Drink Launches Surge in 2015
New Mintel research indicates more energy drinks were launched globally last year than in any year since 2008.
Waters Still Murky for Omega-3s in NDI Draft Guidance?
Nutritional Outlook interviewed the Global Organization for EPA and DHA Omega-3s to find out if conditions have improved at all for omega-3 firms under FDA's new NDI draft guidance document.
Would FDA’s NDI Guidance Really Cost Industry Billions of Dollars?
While some industry experts warn FDA is calling for tens of thousands of new NDI notifications, others anticipate the burden on industry will be more manageable.
Everyone Uses GRAS Panels These Days. But Is the System Working?
GRAS consultants discuss criticisms of GRAS experts.
Dietary Supplements: Made in the USA?
What does “Made in the USA” mean in a global age?
2016 Omega-3 Market Update: Fish Oil, Krill Oil, Astaxanthin, and More
Omega-3 ingredient innovations are bringing life back to a market still in recovery.
LactoSpore Probiotic Granted IBS Health Claim in Canada
The announcement comes just a few months after LactoSpore received a “no questions” letter from FDA regarding its Generally Recognized as Safe (GRAS) submission.
Grief over Grandfathered-Ingredient Lists
Would an official, FDA-created grandfathered list help or hurt the industry?
Latest Sports-Nutrition Product Trends
Sports performance products are gaining fans everywhere, but some product types are proving more popular than others.
Is GRAS Still a Viable NDI Workaround?
Due to uncertainties over the NDI draft guidance, some wonder whether the popular GRAS system will still be a viable option for supplement manufacturers looking to exempt themselves from submitting NDI notifications to FDA.
U.S. Herbal Supplement Sales Climb 7.5% in 2015
Herbal supplement sales increased to a new domestic total of $6.92 billion last year, marking the category’s 12th consecutive year of growth.
Beta Testing Underway for CRN’s Supplement Product Registry
The new finished product registry, developed by Underwriters Laboratory, will be known as the Supplement Online Wellness Library (Supplement OWL).
Company Submits First NDI Master File to FDA. Plus, Will Master Files and Piggybacking Really Be Useful in Practice?
Questions still remain about how practical master files will be in practice.
FTC Charges Journal Publisher OMICS Group with Deceiving Researchers
The FTC alleges OMICS Group made false claims and failed to disclose steep publishing fees.
Whatever Happened to Common-Use GRAS?
Common-use GRAS determinations are no longer common.
Which Ingredient Categories Would Be Hit Hardest by FDA’s NDI Draft Guidance?
Some ingredient types, such as probiotics and synthetic botanicals, may have extra work on their hands as a result of FDA’s revised NDI draft guidance.
Smart Strategies for Marketing Brain-Health Products
Regulators are increasingly scrutinizing product claims in the booming brain-health market.
New Joint-Health Chewable Offers Alternative to Glucosamine and Chondroitin
The Flex Pro ES Chewables combine astaxanthin, hyaluronate, and hydrolyzed eggshell membrane.
Charting the Path Forward on NDI Guidance in a Time of Industry Criticism
How should the dietary supplements industry respond to FDA's new dietary ingredient (NDI) draft guidance, especially in a time of negative criticism?
Negative Industry Attention from State Attorneys General May Be “Diminishing"
At the recent Conference of Western Attorneys General, a panel on the nutritional supplement industry reportedly took on a more positive tone than similar panels conducted last year.
Consulting Our Mates Down Under for NDI Guidance
Australia’s regulatory approach to botanical ingredient changes may inform U.S. companies as they prepare NDI draft guidance comments.
Medical Foods: Creating a Successful GRAS Notification
What’s the best way to ensure a GRAS notification for an ingredient’s use in medical foods will receive a “No Questions” letter from FDA?
FDA’s NDI Guidance Offers Reasonable Take on Ingredient Combinations, CRN’s Mister Says
FDA is “absolutely within its rights” to request a separate NDI notification for ingredient combinations, says CRN’s Steve Mister, and the burden on industry could be minimal.
How FDA’s NDI Guidance Could Paralyze Industry
UNPA points out several provisions in the new NDI draft guidance that could hamstring industry innovation.
4 Ways Brexit Could Affect the Supplement Industry
From maximum vitamin and mineral levels to the future of EFSA, speakers at the recent “Brexit Impact” webinar hosted by AHPA and CRN explain what companies should watch out for.